Chalkboard rounds
A cancer vaccine made for one person?
An individualized mRNA treatment is being tested alongside Keytruda after high-risk melanoma surgery.
Keytruda is the separate anti-PD-1 drug, not the mRNA treatment. Read the Reading Room note for the phase 2b evidence, five-year follow-up and phase 3 topline limits.
Let's talk about it
Leave your thoughts on the post for this story. Where a post is not up yet, the link opens our profile instead.